DiviDrip · BBC

BBC — Virtus Biotech Clinical Trials

BBC is Virtus's Virtus Biotech Clinical Trials (Healthcare). Trading at $42.71. Current dividend yield: 1.49%.

Dividend snapshot

Annual dividend rate$0.65
Current yield1.49%
Payment frequencyAnnually
Next ex-dividend dateDec 22, 2026
Most recent payment dateDec 22, 2025
Last payment amount$0.6554
5-year dividend CAGR
3-year dividend CAGR
Expense ratio0.65%
Payout ratio0%
Market cap$37M
ExchangePCX

Recent dividend payments

DateAmount / share
2025-12-22$0.6550
2024-12-20$0.2400

About BBC

Under normal market conditions, the fund will invest not less than 80% of its assets in component securities of the index. The index seeks to track the performance of the common stock of U.S. exchange-listed biotechnology companies with a primary product offering ("lead drug") that is typically in a Phase 1, Phase 2 or Phase 3 clinical trial stage of development, but prior to receiving marketing approval.

Track BBC in DiviDrip

Add BBC to your portfolio on DiviDrip to track every buy, DRIP reinvestment, and dividend payment in one place. Free, no credit card, no upsell — built by dividend investors, for dividend investors.

Data refreshed 2026-05-23. Not investment advice. Yields and prices change continuously; always verify the latest numbers in the live app before buying.

Related guides

DiviDrip is a free dividend portfolio tracker built by dividend investors, for dividend investors. Try it free — no payment, no upsell, ever. Read the How-To to see how each tool fits together, or browse the Glossary for every term defined plain-English.

Disclaimer: The information provided on this website/service is for informational purposes only and does not constitute financial, investment, or legal advice. Investing in stocks involves high risk, including the loss of principal. We are not responsible for any financial losses or damages resulting from your reliance on this data. Always consult with a qualified financial professional before making investment decisions.

Contact: dividrip@twylightcrow.com© 2026 Twylight Crow

Made with Emergent